My scanner ranks 1,921 US stocks and paper-trades its own picks in public. The 10 fastest growers it still calls cheap (Aug 16)

u/mferarg · Reddit — r/ValueInvesting · August 16, 2026 at 16:59 · ⬆ 18 pts · 💬 15 comments  | View on Reddit ↗
AI Summary

Summary

  • The post describes a quant value scanner covering ~1,921 US stocks, filtering suspect names, and producing a top-10 list of “cheap growers” with large modeled upside to fair value.
  • The author’s thesis: fast revenue growth combined with valuation screens can surface mispriced stocks; highlighted names include ALNY, RGLD, PLMR, MELI, and HL.
  • Quality assessment: This is a structured screen with transparent methodology, but it is not full due diligence. The paper-trading record is young and the author correctly notes the closed-win sample is biased toward fast winners.
Score 18
Comments 15
Upvote % 73%
Full Post Text
Ideas
u/mferarg Reddit r/ValueInvesting
ALNY revenue is up 95% YoY, price is 54% below its 52-week high, and the scanner estimates +106% upside to fair value. If the growth and fair-value model are roughly right, the market may eventually reprice ALNY closer to intrinsic value. The screen flags ALNY as a high-growth name trading like a much weaker business; worth deeper fundamental review. Biotech revenue can be lumpy; clinical/regulatory setbacks or competition could destroy the fair-value case.
u/mferarg Reddit r/ValueInvesting
RGLD revenue is up 94% YoY while the stock sits 25% below its high; the scanner sees +80% upside to fair value. Royal Gold’s royalty/streaming model gives leveraged exposure to precious metals; strong revenue growth may not be fully priced in. This is a momentum-plus-value screen candidate, but commodities and metal prices will drive the real outcome. A sharp decline in gold/silver prices or lower streaming volumes could invalidate the growth signal.
u/mferarg Reddit r/ValueInvesting
MELI trades 28% below its high with revenue growth of 55%, and the scanner shows +99% upside to fair value. E-commerce and fintech scale in Latin America may produce durable compounding; the pullback offers a better entry if growth persists. MELI is a high-quality compounder candidate flagged as undervalued, but macro/currency risk remains. LatAm currency volatility, rising competition, margin pressure, or a growth slowdown could retard re-rating.
u/mferarg Reddit r/ValueInvesting
HL grew revenue 51% over the last twelve months, sits 46% below its 52-week high, and has modeled upside of +68%. Higher metal prices and revenue growth may not be reflected in the stock price given the drawdown from highs. The scanner suggests Hecla is a cheap precious-metals grower, but commodity and operational risks are significant. Silver/gold price declines, mining cost inflation, dilution, or operational setbacks could interrupt the recovery. No other picks from the table were explicitly highlighted in the body, so only the five discussed names are extracted as actionable screen-driven watch ideas.
u/mferarg Reddit r/ValueInvesting
PLMR is growing revenue at 61%, trades at 11.3x forward earnings, and has modeled upside of +94%. Fast-growing specialty insurance at a modest forward multiple may attract value-oriented buyers if underwriting quality holds. The scanner implies the market is pricing PLMR like a slower grower; growth premium may be understated. Insurance claims/catastrophe losses, reserve adjustments, or multiple compression could hurt the thesis.
More from Reddit — r/ValueInvesting

This Reddit post, published August 16, 2026, features u/mferarg discussing ALNY, RGLD, MELI, HL, PLMR. 5 trade ideas extracted by AI with direction and confidence scoring.

Speakers: u/mferarg  · Tickers: ALNY, RGLD, MELI, HL, PLMR